Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
Abstract Liver cirrhosis is the final stage of chronic liver disease (CLD) and is associated with high morbidity and mortality. Various complications such as portal hypertension, ascites retention, hepatic encephalopathy, and hepatorenal syndrome deeply affect patient outcome. The most common tools...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/11754e7c2d96405fa5479faf69d9ced1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:11754e7c2d96405fa5479faf69d9ced1 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:11754e7c2d96405fa5479faf69d9ced12021-11-18T11:25:44ZUpdate on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience2397-907010.1002/jgh3.12667https://doaj.org/article/11754e7c2d96405fa5479faf69d9ced12021-11-01T00:00:00Zhttps://doi.org/10.1002/jgh3.12667https://doaj.org/toc/2397-9070Abstract Liver cirrhosis is the final stage of chronic liver disease (CLD) and is associated with high morbidity and mortality. Various complications such as portal hypertension, ascites retention, hepatic encephalopathy, and hepatorenal syndrome deeply affect patient outcome. The most common tools to predict the outcome of a CLD patient include the following: assessing severity of portal hypertension; scoring systems such as the model of end‐stage liver disease and Child–Pugh score and blood biomarkers related to complications and/or survival rate. In this article, we summarize recent studies of noninvasive markers for predicting impending complications related to CLD and discuss the clinical value of currently available blood biomarkers based on evidence from the literature. In addition, noninvasive blood biomarker assays for different prognostic functions were validated on 113 liver cirrhosis patients at our institution using Kaplan–Meier curve analysis to confirm that these markers can satisfactorily predict CLD‐related patient death.Motoh IwasaRyuta ShigefukuAkiko EguchiYasuyuki TamaiYoshiyuki TakeiWileyarticlebiomarkerchronic liver diseasecomplicationliver cirrhosismortalityDiseases of the digestive system. GastroenterologyRC799-869ENJGH Open, Vol 5, Iss 11, Pp 1250-1256 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
biomarker chronic liver disease complication liver cirrhosis mortality Diseases of the digestive system. Gastroenterology RC799-869 |
| spellingShingle |
biomarker chronic liver disease complication liver cirrhosis mortality Diseases of the digestive system. Gastroenterology RC799-869 Motoh Iwasa Ryuta Shigefuku Akiko Eguchi Yasuyuki Tamai Yoshiyuki Takei Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience |
| description |
Abstract Liver cirrhosis is the final stage of chronic liver disease (CLD) and is associated with high morbidity and mortality. Various complications such as portal hypertension, ascites retention, hepatic encephalopathy, and hepatorenal syndrome deeply affect patient outcome. The most common tools to predict the outcome of a CLD patient include the following: assessing severity of portal hypertension; scoring systems such as the model of end‐stage liver disease and Child–Pugh score and blood biomarkers related to complications and/or survival rate. In this article, we summarize recent studies of noninvasive markers for predicting impending complications related to CLD and discuss the clinical value of currently available blood biomarkers based on evidence from the literature. In addition, noninvasive blood biomarker assays for different prognostic functions were validated on 113 liver cirrhosis patients at our institution using Kaplan–Meier curve analysis to confirm that these markers can satisfactorily predict CLD‐related patient death. |
| format |
article |
| author |
Motoh Iwasa Ryuta Shigefuku Akiko Eguchi Yasuyuki Tamai Yoshiyuki Takei |
| author_facet |
Motoh Iwasa Ryuta Shigefuku Akiko Eguchi Yasuyuki Tamai Yoshiyuki Takei |
| author_sort |
Motoh Iwasa |
| title |
Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience |
| title_short |
Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience |
| title_full |
Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience |
| title_fullStr |
Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience |
| title_full_unstemmed |
Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience |
| title_sort |
update on blood‐based biomarkers for chronic liver diseases prognosis: literature review and institutional experience |
| publisher |
Wiley |
| publishDate |
2021 |
| url |
https://doaj.org/article/11754e7c2d96405fa5479faf69d9ced1 |
| work_keys_str_mv |
AT motohiwasa updateonbloodbasedbiomarkersforchronicliverdiseasesprognosisliteraturereviewandinstitutionalexperience AT ryutashigefuku updateonbloodbasedbiomarkersforchronicliverdiseasesprognosisliteraturereviewandinstitutionalexperience AT akikoeguchi updateonbloodbasedbiomarkersforchronicliverdiseasesprognosisliteraturereviewandinstitutionalexperience AT yasuyukitamai updateonbloodbasedbiomarkersforchronicliverdiseasesprognosisliteraturereviewandinstitutionalexperience AT yoshiyukitakei updateonbloodbasedbiomarkersforchronicliverdiseasesprognosisliteraturereviewandinstitutionalexperience |
| _version_ |
1718420828599615488 |